Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F0A4R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,647
Award facts
- Contract value 100% obligated
- $45,646.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., on January 27, 2026, for the supply of Gemtesa 75 mg tablets (quantity: 90 units) with a ceiling value of $45,646.89. This competitively awarded, non-set-aside contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 28, 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. Gemtesa (mirabegron) is a medication used to treat overactive bladder symptoms, reflecting the company's role in supplying pharmaceutical products for military and federal healthcare systems.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. This comprehensive IDC vehicle enables the company to supply a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen's consistent performance on federal pharmaceutical contracts demonstrates its capability to meet the medical procurement requirements of the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contracting mechanism.
Quick answers
Who was awarded contract SPE2DR26F0A4R?
SPE2DR26F0A4R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F0A4R worth?
The government has obligated $45,647 on SPE2DR26F0A4R.
Is contract SPE2DR26F0A4R an order under another contract?
Yes. SPE2DR26F0A4R is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0A4R competed?
The extent of competition for SPE2DR26F0A4R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award